Good-Lite Funding: How Much Did They Raise & Key Investors

How Much Did Good-Lite Raise?
Funding & Key Investors

Good-Lite, a long-standing manufacturer of vision screening and testing instruments, has secured $349K in total capital, with its most recent financing round bringing in $199K. This significant strategic investment underscores the company's established presence and ongoing relevance in the ophthalmic diagnostics market.

What is Good-Lite?

Good-Lite

Manufacturing

Medical Devices & Equipment

Since its inception in 1930, the Good-Lite Company has dedicated itself to producing high-quality, hand-held vision screening and testing instruments designed to ensure lifelong visual health. The company is particularly recognized for its comprehensive Lea Test System, which includes the LEA Symbols® and LEA Numbers® tests. These tools are crucial for assessing various aspects of vision, including cortical visual impairment, high and low contrast sensitivity, and color vision, serving a critical role in both clinical and educational settings.

How much funding has Good-Lite raised?

Good-Lite has raised a total of $349K across 2 funding rounds:

2020

Debt

$150K

2021

Debt

$199K

Debt (2020): $150K with participation from PPP

Debt (2021): $199K led by PPP

What's next for Good-Lite?

The substantial late-stage funding context suggests Good-Lite is poised for significant expansion or strategic initiatives. This capital infusion will likely fuel advancements in product development, enhance manufacturing capabilities, and broaden market reach for its specialized vision testing equipment. The company's focus on foundational visual health tools positions it to capitalize on increasing awareness and demand for early detection and management of visual impairments.

See full Good-Lite company page

See More Financial Insights